Skip to content
Open access

Genome-wide analysis of common structural variants in Alzheimer's disease identifies a risk-associated regulatory CCG repeat in FAM193B.

Oct 2026 · Nature Neuroscience · 0 citations · 65 references
Medicine

TL;DR

The common FAM193B-CCG repeat is established as an AD risk genetic factor and the contribution of common SVs to AD heritability is highlighted to highlight the contribution of common SVs to AD heritability.

Abstract

Although Alzheimer's disease (AD) has a polygenic architecture, with numerous associated single-nucleotide polymorphisms (SNPs) identified, the contribution of structural variants (SVs) is unclear. In this study, using long-read (n = 11) and short-read (n = 3,190) sequencing data from the Chinese population, we show that common SVs contribute to AD heritability beyond common SNPs. We identify an expanded CCG repeat in the FAM193B promoter that shows a genome-wide significant association with increased AD risk (odds ratio = 2.20 per 10-repeat increase, P = 5.5 × 10-13). The expanded FAM193B-CCG repeat increases FAM193B expression and mediates the pleiotropic association between brain FAM193B expression and AD risk. Analyses of postmortem human brains and cultured neuronal cells show that elevated neuronal FAM193B expression is associated with DNA damage and cell death-related pathways. These findings establish the common FAM193B-CCG repeat as an AD risk genetic factor and highlight the contribution of common SVs to AD heritability.

Read PDF

Similar papers

Review Open access Sep 2026

Alzheimer’s disease: genetic background in the era of next-generation sequencing technologies

This review synthesizes current understanding of the genetic architecture of Alzheimer’s disease in the era of next-generation sequencing, with particular emphasis on variant classes beyond single nucleotide polymorphisms, and discusses somatic mosaicism that represents another layer of its complexity.

L. Lukyova, A. Zaťková, J. Minarík et al. · 0 citations
Open access Nov 2026

A genome-wide association study and genetic risk score for age at diabetes diagnosis support beta-cell dysfunction in young-onset diabetes in Chinese

We investigated genetic variations driving young age-at-diabetes-diagnosis (ADD) and developed a genetic risk score (GRS) to identify Chinese individuals at risk of young-onset diabetes (YOD with ADD<40). We performed genome-wide association studies (GWAS) for ADD with internal and external replication in 22,611 indivi...

B. Fan, Claudia H. T. Tam, A. Luk et al. · 0 citations
Open access Oct 2026

Non-Coding Structural Variants in Regulatory Regions and High Polygenic Burden May Jointly Contribute to Early-Onset Familial Hashimoto’s Thyroiditis

Background/Objectives: Multigenerational families with unusually early disease onset provide a unique opportunity to investigate the genetic architecture underlying the missing heritability of complex diseases. Here, we investigated the genetic basis of apparent autosomal dominant early-onset Hashimoto’s thyroiditis (H...

Vesna Boraska Perica, Ana Barić Žižić, S. Sladic et al. · 0 citations
Open access Oct 2026

The Alzheimer’s disease-associated rs28834970 variant in PTK2B impairs electrical activity and regulates Tau phosphorylation and APP processing in human neuronal cultures

Background Genome-wide association studies have identified the PTK2B gene, which encodes Proline-rich tyrosine kinase 2 (PYK2), as a genetic risk factor for Alzheimer’s disease (AD). However, its role in AD aetiology remains to be understood, as a complex contribution to amyloid β (Aβ) toxicity, tauopathy and neuronal...

Nina Lannette-Weimann, M. Huyvaert, Floriane Limoge et al. · 0 citations
Open access Oct 2026

Expression predictions inform molecular interpretation of Alzheimer's disease risk loci

Sequence models predict the molecular effects of genetic variation, yet their contribution to interpreting Alzheimer's disease (AD) association signals remains uncertain. Here we analysed AlphaGenome Atlas predictions for 111,446 common variants across 75 regions from a European-ancestry genome-wide association study (...

C. B. Hyug, J. Jeong · 0 citations
Review Open access Oct 2026

Chromosome 21 gene dosage and Alzheimer's disease in Down syndrome: DYRK1A mechanism and its translation to blood-based biomarkers.

Down syndrome (DS), caused by trisomy 21, is the most common genetic cause of early-onset Alzheimer's disease (AD). Virtually all individuals with DS develop AD neuropathology by the fourth decade of life, and the majority develop clinical dementia by the seventh decade. Triplication of the APP gene on chromosome 21 (H...

Ainaz Shateri · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.